TickerFacts.

Natera, Inc. (NTRA): Operating Cash Flow

Annual figures by period end, from SEC filings.

$215.30M
Year ended 2025-12-31
$228.24M
Trailing 12 months to 2026-06-30
2013-12-31: -$24.13M2014-12-31: $10.49M2015-12-31: -$37.83M2016-12-31: -$74.05M2017-12-31: -$97.83M2018-12-31: -$70.58M2019-12-31: -$63.44M2020-12-31: -$182.51M2021-12-31: -$335.24M2022-12-31: -$431.50M2023-12-31: -$246.96M2024-12-31: $135.66M2025-12-31: $215.30M$215.30M
2013-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$215.30M+58.7%2026-02-27, From 2025-01-01
2024-12-31$135.66Mn/m2026-02-27, From 2024-01-01
2023-12-31-$246.96Mn/m2026-02-27, From 2023-01-01
2022-12-31-$431.50Mn/m2025-02-28, From 2022-01-01
2021-12-31-$335.24Mn/m2024-02-29, From 2021-01-01
2020-12-31-$182.51Mn/m2023-03-01, From 2020-01-01
2019-12-31-$63.44Mn/m2022-02-25, From 2019-01-01
2018-12-31-$70.58Mn/m2021-02-26, From 2018-01-01
2017-12-31-$97.83Mn/m2020-03-02, From 2017-01-01
2016-12-31-$74.05Mn/m2019-03-15, From 2016-01-01
2015-12-31-$37.83Mn/m2018-03-15, From 2015-01-01
2014-12-31$10.49Mn/m2017-03-16, From 2014-01-01
2013-12-31-$24.13Mn/a2016-03-24, From 2013-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Natera, Inc. (NTRA)2025-12-31$215.30M+58.7%
RadNet, Inc. (RDNT)2025-12-31$298.82M+28.2%
Fortrea Holdings Inc. (FTRE)2025-12-31$113.50M-56.8%
Guardant Health, Inc. (GH)2025-12-31-$184.76Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$83.16Mn/m
Veracyte, Inc. (VCYT)2025-12-31$136.31M+81.5%
Quest Diagnostics Inc (DGX)2025-12-31$1.89B+41.4%
Labcorp Holdings Inc. (LH)2025-12-31$1.64B+3.4%
CareDx, Inc. (CDNA)2025-12-31$42.03M+10.5%

Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗